1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Cognition Disorders

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bromley-Brits, K; Cai, F; Chen, B; He, G; Song, W; Zhang, X	1

Other Studies

1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Cognition Disorders

Article	Year
Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model. Current Alzheimer research, 2010, Volume: 7, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Female; Humans; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Treatment Failure	2010

Article

Year

Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model.

Current Alzheimer research, 2010, Volume: 7, Issue:3

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Female; Humans; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Treatment Failure

2010